PENTOXIFYLLINE Side Effects

6790412-3 | Hepatitis Cholestatic, Jaundice, Pyrexia
on Jun 29, 2009 Female patient from FRANCE , 44 years of age, was treated with Pentoxifylline (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic, jaundice (What is jaundice?), pyrexia. Pentoxifylline dosage: Dose Unit: 400 Mg. During the same period patient was treated with OXYBUTYNIN CHLORIDE (Dose Unit: 5 Mg) (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), CYMBALTA (Dose Unit: 30 Mg) (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), ARIXTRA (View Arixtra Review and Arixtra Label ), ATARAX (Dose Unit: 100 Mg) (View Atarax Review and Atarax Label ), CORTANCYL (Dose Unit: 5 Mg) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6776562-6 | Peripheral Vascular Disorder, Pulse Absent
Patient was taking Pentoxifylline (View Usage). Patient had the following side effects: peripheral vascular disorder, pulse absent on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and. Pentoxifylline dosage: . During the same period patient was treated with DAPAGLIFLOZIN (DAPAGLIFLOZIN) (10 Mg;qd; Po) (View Dapagliflozin (dapagliflozin) Review and Dapagliflozin (dapagliflozin) Label ), TRANDOLAPRIL (2 Mg; Qd; Po) (View Trandolapril Review and Trandolapril Label ), SPIRONOLACTONE (2 Mg;qd; Po) (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (6 Mg; Qd; Po) (View Furosemide Review and Furosemide Label ), ACTRAPID HUMAN (INSULIN HUMAN) (1 Df;qd; Parn) (View Actrapid Human (insulin Human) Review and Actrapid Human (insulin Human) Label ), INSULATARD NPH HUMAN (1 Df;qd; Parn) (View Insulatard Nph Human Review and Insulatard Nph Human Label ), METFORMIN HYDROCHLORIDE (2550 Mg;qd; Po) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

6755662-0 | Condition Aggravated, Peripheral Vascular Disorder
Adverse event was reported on May 19, 2010 by a Female patient taking Pentoxifylline (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: UNITED STATES , 69 years of age, After Pentoxifylline was administered, patient had the following side effects: condition aggravated, peripheral vascular disorder. During the same period patient was treated with DAPAGLIFLOZIN (DAPAGLIFLOZIN) (10 Mg;qd; Po) (View Dapagliflozin (dapagliflozin) Review and Dapagliflozin (dapagliflozin) Label ), TRANDOLAPRIL (2 Mg;qd; Po) (View Trandolapril Review and Trandolapril Label ), SPIRONOLACTONE (2 Mg;qd; Po) (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (6 Mg;qd; Po) (View Furosemide Review and Furosemide Label ), ACTRAPID HUMAN (INSULIN HUMAN) (1 Df;qd; Parn) (View Actrapid Human (insulin Human) Review and Actrapid Human (insulin Human) Label ), INSULATARD NPH HUMAN (1 Df;qd; Parn) (View Insulatard Nph Human Review and Insulatard Nph Human Label ), METFORMIN HCL (2550 Mg;qd; Po) (View Metformin Hcl Review and Metformin Hcl Label ).

6575863-4 | Myotonia, Pain
on Jan 26, 2010 Female patient from GERMANY , 27 years of age, was diagnosed with tinnitus (What is tinnitus?) and was treated with Pentoxifylline (View Usage). Patient experienced the following unwanted or unexpected effects: myotonia, pain (What is pain?). Pentoxifylline dosage: .


6355667-8 | Hallucination, Auditory
on Aug 28, 2009 Male patient from CANADA , 60 years of age, was diagnosed with cardiovascular disorder and was treated with Pentoxifylline (View Usage). Patient had the following side effects: hallucination, auditory. Pentoxifylline dosage: 400 Mg;tab;po;qd; 400 Mg;qd; Po.

6282897-6 | Amnesia, Blood Pressure Fluctuation, Chest Pain, Confusional State, Dizziness, Epistaxis, Headache, Nasal Congestion, Pruritus
Patient was taking Pentoxifylline (View Usage). After Pentoxifylline was administered, patient had the following side effects: amnesia, blood pressure fluctuation, chest pain (What is chest pain?), confusional state, dizziness (What is dizziness?), epistaxis, headache (What is headache?), nasal congestion, pruritus on Jul 08, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with impaired healing and. Pentoxifylline dosage: 400 Mg, Bid, Po.

6254993-0 | Hallucination, Auditory
Adverse event was reported on Jun 19, 2009 by a Male patient taking Pentoxifylline (View Usage) (Dosage: 400 Mg;qd;po) was diagnosed with cardiovascular disorder and. Location: CANADA , 60 years of age, Patient experienced the following unwanted or unexpected effects: hallucination, auditory.

6170937-4 | Neutropenia, Therapeutic Response Decreased, White Blood Cell Count Decreased
on Apr 23, 2009 Male patient from UNITED STATES , 76 years of age, was diagnosed with gangrene, renal failure chronic and was treated with Pentoxifylline (View Usage). Patient had the following side effects: neutropenia, therapeutic response decreased, white blood cell count decreased. Pentoxifylline dosage: Po. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), NADOLOL (View Nadolol Review and Nadolol Label ), CALCIUM (View Calcium Review and Calcium Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ). Patient was hospitalized.

6145810-8 | Anorexia, Diarrhoea, Dizziness, Dysstasia, Heart Rate Increased, Muscular Weakness, Vomiting
on Apr 06, 2009 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with pain in extremity and was treated with Pentoxifylline (View Usage). After Pentoxifylline was administered, patient had the following side effects: anorexia, diarrhoea, dizziness (What is dizziness?), dysstasia, heart rate increased, muscular weakness, vomiting. Pentoxifylline dosage: 1 Tab 3 Times A Day. Patient was hospitalized and became disabled.

5947629-7 | Abdominal Pain, Back Pain, Blood Pressure Increased, Chest Discomfort, Condition Aggravated, Constipation, Dizziness, Gastric Cancer
Patient was taking Pentoxifylline (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), blood pressure increased, chest discomfort, condition aggravated, constipation (What is constipation?), dizziness (What is dizziness?), gastric cancer on Oct 22, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 171.0 lb, was diagnosed with peripheral vascular disorder and. Pentoxifylline dosage: (400 Mg Tid Oral). During the same period patient was treated with TRENTAL ((400 Mg Tid Oral)) (View Trental Review and Trental Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), NADOLOL (View Nadolol Review and Nadolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5881517-X | Abdominal Pain, Back Pain, Chest Discomfort, Condition Aggravated, Constipation, Dizziness, Headache, Nausea, Peripheral Vascular Disorder
Adverse event was reported on Dec 17, 2007 by a Male patient taking Pentoxifylline (View Usage) (Dosage: (400 Mg Tid Oral)) was diagnosed with peripheral vascular disorder and. Location: UNITED STATES , weighting 171.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), chest discomfort, condition aggravated, constipation (What is constipation?), dizziness (What is dizziness?), headache (What is headache?), nausea (What is nausea?), peripheral vascular disorder. During the same period patient was treated with TRENTAL (Df) (View Trental Review and Trental Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), NADOLOL (View Nadolol Review and Nadolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5674155-5 | Myocardial Infarction, Oedema, Pruritus, Urticaria
on Mar 17, 2008 Male patient from SPAIN , 46 years of age, was diagnosed with chest pain (What is chest pain?) and was treated with Pentoxifylline (View Usage). After Pentoxifylline was administered, patient had the following side effects: myocardial infarction, oedema, pruritus, urticaria. Pentoxifylline dosage: . During the same period patient was treated with CAFFEINE CITRATE (View Caffeine Citrate Review and Caffeine Citrate Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

5597643-9 | Dry Skin, Epistaxis, Prostate Cancer Recurrent
on Jan 04, 2008 Male patient from CANADA , 75 years of age, was diagnosed with raynaud's phenomenon and was treated with Pentoxifylline (View Usage). Patient experienced the following unwanted or unexpected effects: dry skin, epistaxis, prostate cancer recurrent. Pentoxifylline dosage: 400 Mg;tab;po;tid, 400 Mg;tab;po;tid, 400 Mg;tab;po;tid. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

5346014-9 | Erythema, Haemorrhage, Myoglobinaemia, Pancytopenia, Renal Failure, Rhabdomyolysis, Sepsis, Toxic Epidermal Necrolysis, Transaminases Increased
Patient was taking Pentoxifylline (View Usage). Patient had the following side effects: erythema, haemorrhage, myoglobinaemia, pancytopenia, renal failure, rhabdomyolysis, sepsis (What is sepsis?), toxic epidermal necrolysis, transaminases increased on May 24, 2007 from FRANCE Additional patient health information: Male patient , 85 years of age, was diagnosed with prophylaxis, vitamin supplementation, anaemia of malignant disease and. Pentoxifylline dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), VITAMIN B12 + FOLIC ACID (View Vitamin B12 + Folic Acid Review and Vitamin B12 + Folic Acid Label ), ALIMTA (870 Mg, Other) (View Alimta Review and Alimta Label ), ZOFRAN (View Zofran Review and Zofran Label ), ARANESP /UNK/ (View Aranesp /unk/ Review and Aranesp /unk/ Label ). Patient was hospitalized.

5055853-3 | Asthenia, Constipation, Delirium, Dizziness, Fatigue, Gastrointestinal Erosion, Gastrointestinal Haemorrhage, Haemorrhoid Operation, Refusal Of Treatment By Patient
Adverse event was reported on Jul 18, 2006 by a Male patient taking Pentoxifylline (View Usage) (Dosage: 400 Mg Tid Po) was diagnosed with peripheral vascular disorder, coronary artery bypass (What is coronary artery bypass?) and. Location: UNITED STATES , 55 years of age, weighting 235.9 lb, After Pentoxifylline was administered, patient had the following side effects: asthenia, constipation (What is constipation?), delirium, dizziness (What is dizziness?), fatigue, gastrointestinal erosion, gastrointestinal haemorrhage, haemorrhoid operation, refusal of treatment by patient. During the same period patient was treated with CLOPIDOGREL (75 Mg Qd Po) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

4984718-8 | Anaemia, Aortic Stenosis, Aortic Valve Disease, Aortic Valve Stenosis, Appendicitis, Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, Brain Natriuretic Peptide Increased
on Oct 10, 2005 Female patient from UNITED STATES , 76 years of age, weighting 200.6 lb, was treated with Pentoxifylline (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, aortic stenosis, aortic valve disease, aortic valve stenosis, appendicitis (What is appendicitis?), blood creatinine increased, blood pressure decreased, blood urea increased, brain natriuretic peptide increased. Pentoxifylline dosage: . During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), COZAAR (View Cozaar Review and Cozaar Label ), NITRO DUR (View Nitro-dur Review and Nitro-dur Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), NITROQUICK (View Nitroquick Review and Nitroquick Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

4950845-4 | Alanine Aminotransferase Increased, Cerebral Disorder, Deafness, Gamma-glutamyltransferase Increased, Liver Function Test Abnormal, Nuclear Magnetic Resonance Imaging Abnormal, Uveitis, Vasculitis
on Feb 22, 2004 Male patient from GERMANY , weighting 198.4 lb, was diagnosed with corneal transplant and was treated with Pentoxifylline (View Usage). Patient had the following side effects: alanine aminotransferase increased, cerebral disorder, deafness, gamma-glutamyltransferase increased, liver function test abnormal, nuclear magnetic resonance imaging abnormal, uveitis, vasculitis (What is vasculitis?). Pentoxifylline dosage: . During the same period patient was treated with DECORTIN (5 Mg, Qd) (View Decortin Review and Decortin Label ), LEGALON (View Legalon Review and Legalon Label ), COSOPT (View Cosopt Review and Cosopt Label ), INFLANEFRAN (View Inflanefran Review and Inflanefran Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ), SANDIMMUNE (240mg/day) (View Sandimmune Review and Sandimmune Label ), ADSORBONAC (View Adsorbonac Review and Adsorbonac Label ).

4756568-9 | Feeling Hot, Hypoglycaemia, Syncope
Patient was taking Pentoxifylline (View Usage). After Pentoxifylline was administered, patient had the following side effects: feeling hot, hypoglycaemia, syncope on Aug 19, 2005 from Additional patient health information: Female patient , 79 years of age, was diagnosed with intermittent claudication, diabetes mellitus and. Pentoxifylline dosage: . During the same period patient was treated with NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), ZOCOR (View Zocor Review and Zocor Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), LASIX (View Lasix Review and Lasix Label ), CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ). Patient was hospitalized.

4692983-X | Abdominal Discomfort
Adverse event was reported on Feb 23, 2005 by a Female patient taking Pentoxifylline (View Usage) (Dosage: 400 Mg Po Bid) was diagnosed with peripheral occlusive disease, polyarteritis nodosa and. Location: , 66 years of age, Patient experienced the following unwanted or unexpected effects: abdominal discomfort. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), DAPSONE (View Dapsone Review and Dapsone Label ).

4579630-2 | Completed Suicide, Hypotension, Intentional Misuse, Oxygen Saturation Decreased, Respiratory Distress, Tachycardia
on Jan 26, 2005 Female patient from , 84 years of age, was treated with Pentoxifylline (View Usage). Patient had the following side effects: completed suicide, hypotension, intentional misuse, oxygen saturation decreased, respiratory distress, tachycardia. Pentoxifylline dosage: Po.